Back to Journals » Breast Cancer: Targets and Therapy » Volume 15

Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing

Total article views   HTML views PDF downloads Totals
3,255 Dovepress* 3,129+ 138 3,267
PubMed Central* 126 91 217
Totals 3,255 229 3,484
*Since 3 August 2023
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar